Maintaining healthy kidneys is crucial for overall well-being. The kidneys play a vital role in filtering waste from the ...

Women diagnosed early in pregnancy with a fetus lacking adequate kidney function to make the urine that serves as vital ...

Trutakna, priced at $425,000 per year, is the first drug approved in the U.S. that targets both BAFF and APRIL proteins ...

A pilot randomized controlled trial in patients with stage 3 chronic kidney disease found that adding roughly one liter of ...

Finerenone shows promise in slowing chronic kidney disease progression in non-diabetic patients, according to recent global ...

One subtle change after waking up can be easy to dismiss, especially when it fades later in the day. But when it keeps ...

Scientists have made a remarkable breakthrough in kidney research. In a paper published in the journal Communications Biology, a team of researchers at Kyoto University led by Ramin Sadeghian present ...

Otsuka’s Voyxact was granted accelerated approval from the FDA in November 2025 based on nine-month data.

When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no ...

Vera Therapeutics has won FDA approval for Trutakna, a BAFF/APRIL inhibitor for IgA nephropathy (IgAN) that will compete with ...